Marker Therapeutics Inc. diskutieren
Marker Therapeutics Inc.
WKN: A3D5YK / Symbol: MRKR / Name: Marker Therapeutics / Aktie / Small Cap /
1,01 €
-0,98 %
Marker Therapeutics, Inc. (NASDAQ: MRKR) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $11.00 price target on the stock.
Ratings data for MRKR provided by MarketBeat
Marker Therapeutics, Inc. (NASDAQ: MRKR) had its price target raised by analysts at LADENBURG THALM/SH SH from $11.00 to $19.00. They now have a "buy" rating on the stock.
Ratings data for MRKR provided by MarketBeat
Marker Therapeutics, Inc. (NASDAQ: MRKR) had its "strong-buy" rating re-affirmed by analysts at WBB Securities. They now have a $12.50 price target on the stock.
Ratings data for MRKR provided by MarketBeat
Marker Therapeutics (NASDAQ:MRKR) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for MRKR provided by MarketBeat
Marker Therapeutics (NASDAQ:MRKR) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Ratings data for MRKR provided by MarketBeat
Marker Therapeutics (NASDAQ:MRKR) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for MRKR provided by MarketBeat
Marker Therapeutics (NASDAQ:MRKR) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
Ratings data for MRKR provided by MarketBeat
Marker Therapeutics (MRKR) had its "buy" rating reaffirmed by HC Wainwright.
Ratings data for MRKR provided by MarketBeat
Neueste Beiträge
BMO_Capital_Markets in Empire Co. Ltd A diskutieren